Production (Stage)
Instil Bio, Inc.
TIL
$35.46
$2.577.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.68% | -12.22% | -10.33% | -7.05% | -6.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.42% | -5.28% | -44.85% | -31.79% | -41.93% |
| Operating Income | 26.42% | 5.28% | 44.85% | 31.79% | 41.93% |
| Income Before Tax | -16.04% | 7.97% | 65.86% | 20.07% | 57.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.04% | 7.97% | 65.86% | 20.07% | 57.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.04% | 7.97% | 65.86% | 20.07% | 57.42% |
| EBIT | 26.42% | 5.28% | 44.85% | 31.79% | 41.93% |
| EBITDA | 25.18% | 3.70% | 46.78% | 33.36% | 41.81% |
| EPS Basic | -15.53% | 8.28% | 65.86% | 20.07% | 57.42% |
| Normalized Basic EPS | 39.76% | 4.57% | 49.61% | 18.38% | 38.41% |
| EPS Diluted | -15.53% | 8.28% | 65.86% | 20.09% | 57.42% |
| Normalized Diluted EPS | 39.76% | 4.57% | 49.61% | 18.38% | 38.41% |
| Average Basic Shares Outstanding | 0.44% | 0.34% | 0.01% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.44% | 0.34% | 0.01% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |